Compare EMO & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMO | BLFS |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 923.5M |
| IPO Year | N/A | 2013 |
| Metric | EMO | BLFS |
|---|---|---|
| Price | $51.99 | $24.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 51.9K | ★ 402.8K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 6.70% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ N/A | $1,201.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $41.54 | $17.86 |
| 52 Week High | $54.90 | $29.57 |
| Indicator | EMO | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 67.57 |
| Support Level | $51.00 | $23.74 |
| Resistance Level | $52.03 | $26.30 |
| Average True Range (ATR) | 0.88 | 1.12 |
| MACD | 0.24 | 0.25 |
| Stochastic Oscillator | 74.55 | 95.22 |
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.